Genomic Health v EUIPO (Oncotype Dx Genomic Prostate Score): ECFI 23 Apr 2018

Intellectual, Industrial and Commercial Property – Judgment – EU trade mark – Application for EU word mark ONCOTYPE DX GENOMIC PROSTATE SCORE – Absolute ground for refusal – Descriptiveness – Article 7(1)(c) of Regulation (EC) No 207/2009 (now Article 7(1)(c) of Regulation (EU) 2017/1001) – Equal treatment

Citations:

ECLI:EU:T:2018:212, [2018] EUECJ T-354/17

Links:

Bailii

Jurisdiction:

European

Intellectual Property

Updated: 14 April 2022; Ref: scu.609309